Literature DB >> 17192274

PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation.

Fubo Liang1, Jiao Liang, Wei-Qing Wang, Jin-Peng Sun, Eshwar Udho, Zhong-Yin Zhang.   

Abstract

Phosphatase of regenerating liver 3 (PRL3) is overexpressed in a variety of tumors, and high levels of PRL3 expression are associated with tumorigenesis and metastasis. Consistent with an oncogenic role for PRL3, we show that ectopic PRL3 expression promotes cell proliferation and invasion. However, little is known about the molecular basis for PRL3 function. Obtaining this knowledge is vital for understanding PRL3-mediated disease processes and for the development of novel anticancer therapies targeted to PRL3. Here we report that up-regulation of PRL3 activates the Src kinase, which initiates a number of signal pathways culminating in the phosphorylation of ERK1/2, STAT3, and p130(Cas). The activation of these pathways likely contributes to the increased cell growth and motility of PRL3 cells. We provide evidence that PRL3 induces Src activation through down-regulation of Csk, a negative regulator of Src. Importantly, Src activation and Csk down-regulation are also observed in colon cancer cells expressing a higher level of PRL3. Thus, we have revealed a biochemical mechanism for the PRL3-mediated cell invasion and proliferation in which elevated PRL3 expression causes a reduction in Csk level, leading to Src activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17192274     DOI: 10.1074/jbc.M608940200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  75 in total

1.  Protein-tyrosine phosphatase 4A3 (PTP4A3) promotes vascular endothelial growth factor signaling and enables endothelial cell motility.

Authors:  Mark W Zimmerman; Kelley E McQueeney; Jeffrey S Isenberg; Bruce R Pitt; Karla A Wasserloos; Gregg E Homanics; John S Lazo
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

2.  PRL2/PTP4A2 phosphatase is important for hematopoietic stem cell self-renewal.

Authors:  Michihiro Kobayashi; Yunpeng Bai; Yuanshu Dong; Hao Yu; Sisi Chen; Rui Gao; Lujuan Zhang; Mervin C Yoder; Reuben Kapur; Zhong-Yin Zhang; Yan Liu
Journal:  Stem Cells       Date:  2014-07       Impact factor: 6.277

3.  The Hippo pathway promotes cell survival in response to chemical stress.

Authors:  F Di Cara; T M Maile; B D Parsons; A Magico; S Basu; N Tapon; K King-Jones
Journal:  Cell Death Differ       Date:  2015-03-13       Impact factor: 15.828

Review 4.  Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases.

Authors:  Zhi-Hong Yu; Zhong-Yin Zhang
Journal:  Chem Rev       Date:  2017-05-25       Impact factor: 60.622

Review 5.  TGF-beta signaling in cancer: post-transcriptional regulation of EMT via hnRNP E1.

Authors:  Breege V Howley; Philip H Howe
Journal:  Cytokine       Date:  2018-02-01       Impact factor: 3.861

Review 6.  Phosphatase of regenerating liver in hematopoietic stem cells and hematological malignancies.

Authors:  Michihiro Kobayashi; Sisi Chen; Rui Gao; Yunpeng Bai; Zhong-Yin Zhang; Yan Liu
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

7.  Genomic aberrations in hepatocellular carcinoma related to osteopontin expression detected by array-CGH.

Authors:  Jin-Cai Wu; Bing-Sheng Sun; Ning Ren; Qing-Hai Ye; Lun-Xiu Qin
Journal:  J Cancer Res Clin Oncol       Date:  2009-10-16       Impact factor: 4.553

Review 8.  Phosphatase of regenerating liver: a novel target for cancer therapy.

Authors:  Amanda M Campbell; Zhong-Yin Zhang
Journal:  Expert Opin Ther Targets       Date:  2014-03-01       Impact factor: 6.902

9.  PRL-3 overexpression in epithelial cells is induced by surrounding stromal fibroblasts.

Authors:  David G Molleví; Alvaro Aytes; Mireia Berdiel; Laura Padullés; Maria Martínez-Iniesta; Xavier Sanjuan; Ramon Salazar; Alberto Villanueva
Journal:  Mol Cancer       Date:  2009-07-08       Impact factor: 27.401

10.  PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1-ERK1/2 and-MMP2 signaling.

Authors:  Lirong Peng; Xiaofang Xing; Weijun Li; Like Qu; Lin Meng; Shenyi Lian; Beihai Jiang; Jian Wu; Chengchao Shou
Journal:  Mol Cancer       Date:  2009-11-24       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.